CorMedix (CRMD) Net Margin (2016 - 2025)
Historic Net Margin for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to 104.08%.
- CorMedix's Net Margin rose 1283700.0% to 104.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 76.76%, marking a year-over-year increase of 4128800.0%. This contributed to the annual value of 41.24% for FY2024, which is 1395304800.0% down from last year.
- CorMedix's Net Margin amounted to 104.08% in Q3 2025, which was up 1283700.0% from 55.0% recorded in Q2 2025.
- Over the past 5 years, CorMedix's Net Margin peaked at 192678.48% during Q2 2023, and registered a low of 100538.67% during Q3 2022.
- Moreover, its 5-year median value for Net Margin was 4130.85% (2021), whereas its average is 33627.76%.
- In the last 5 years, CorMedix's Net Margin soared by 1748493100bps in 2023 and then plummeted by -1944333400bps in 2024.
- Quarter analysis of 5 years shows CorMedix's Net Margin stood at 13814.54% in 2021, then plummeted by -100bps to 27637.7% in 2022, then soared by 369bps to 74310.64% in 2023, then tumbled by -100bps to 43.14% in 2024, then surged by 141bps to 104.08% in 2025.
- Its Net Margin stands at 104.08% for Q3 2025, versus 55.0% for Q2 2025 and 52.82% for Q1 2025.